Universal reference book for medicines
Product name: PARA PLUS (PARA PLUS)

Active substance: malathion, permethrin, piperonyl butoxide

Type: The drug for the treatment of pediculosis of the scalp

Manufacturer: Laboratoires OMEGA PHARMA FRANCE (France) manufactured by AEROFARM (France)
Composition, form of production and packaging
?
Aerosol for external use in the form of a transparent oily solution with a yellowish tinge, with a slight characteristic odor; sprayed into small particles.
100 g solution 1 bottle

malathion 500 mg 290 mg

permethrin 1 g 580 mg

piperonyl butoxide 4 g 2.32 g

Excipients: isododecane - 54.81 g, propellant HFA 134a - 58 g.

116 g - aerosol aluminum cylinders with a continuous valve and a spraying device (1) - packs of cardboard.

INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2012.

PHARMACHOLOGIC EFFECT

Combination drug for the treatment of pediculosis of the scalp.

Pharmacological action of the drug is due to the presence of active substances that have an insecticidal effect.
Permethrin is a neurotoxic poison for insects. Piperonyl butoxide enhances the action of permethrin. Malathion is an organophosphorous insecticide.
PHARMACOKINETICS

Data on the pharmacokinetics of Para Plus are not available.

INDICATIONS

- Treatment of pediculosis of the scalp (effect on lice and nits).

DOSING MODE

Short-term pressing the drug is sprayed on the scalp and the entire length of the hair.
Exposure of the drug is 10 minutes, while the head is not covered. Then the head needs to be washed with shampoo. Dead insects comb out a frequent comb.
In case of extensive infection, it is recommended to repeat the treatment in a week.

SIDE EFFECT

Local reactions: very rarely - a feeling of slight tingling or burning of the scalp.

CONTRAINDICATIONS

- bronchial asthma;

- Children's age up to 2.5 years;

- Hypersensitivity to the components of the drug.

PREGNANCY AND LACTATION

Adequate and strictly controlled studies of the safety of the use of Para plus in pregnancy and lactation (breastfeeding) was not conducted.

The use of the drug during pregnancy and lactation (breastfeeding) is possible only if the intended benefit to the mother exceeds the potential risk to the fetus or child.

APPLICATION FOR CHILDREN

Contraindicated in children under the age of 2.5 years.

Use in children older than 2.5 years is possible according to the dosing regimen.

SPECIAL INSTRUCTIONS

The drug should be sprayed in a well-ventilated area.
During spraying and exposure, the drug should be away from the fire.
Avoid contact with eyes and mucous membranes.
In case of accidental contact with eyes, rinse thoroughly with warm water.
To avoid re-infection, all textile products with which the patient has contacted (including pillows, headgear, clothing collars) should be treated.

Impact on the ability to drive vehicles and manage mechanisms

There is no evidence of a negative effect of the drug on the ability to drive and other vehicles.

OVERDOSE

At present, cases of drug overdose Para Plus have not been reported.

DRUG INTERACTION

Drug interaction of the drug Para plus is not revealed.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored out of reach of children at a temperature of no higher than 30 ° C.
Shelf life - 4 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!